Back to Search
Start Over
Suppression of oxidative stress and 5-lipoxygenase activation by edaravone improves depressive-like behavior after concussion.
- Source :
-
Journal of neurotrauma [J Neurotrauma] 2014 Oct 15; Vol. 31 (20), pp. 1689-99. Date of Electronic Publication: 2014 Aug 21. - Publication Year :
- 2014
-
Abstract
- Brain concussions are a serious public concern and are associated with neuropsychiatric disorders, such as depression. Patients with concussion who suffer from depression often experience distress. Nevertheless, few pre-clinical studies have examined concussion-induced depression, and there is little information regarding its pharmacological management. Edaravone, a free radical scavenger, can exert neuroprotective effects in several animal models of neurological disorders. However, the effectiveness of edaravone in animal models of concussion-induced depression remains unclear. In this study, we examined whether edaravone could prevent concussion-induced depression. Mice were subjected to a weight-drop injury and intravenously administered edaravone (3.0 mg/kg) or vehicle immediately after impact. Serial magnetic resonance imaging showed no abnormalities of the cerebrum on diffusion T1- and T2-weighted images. We found that edaravone suppressed concussion-induced depressive-like behavior in the forced swim test, which was accompanied by inhibition of increased hippocampal and cortical oxidative stress (OS) and suppression of 5-lipoxygenase (5-LOX) translocation to the nuclear envelope in hippocampal astrocytes. Hippocampal OS in concussed mice was also prevented by the nicotinamide adenine dinucleotide phosphate oxidase inhibitor, apocynin, and administration of BWB70C, a 5-LOX inhibitor, immediately and 24 h after injury prevented depressive-like behaviors in concussed mice. Further, antidepressant effects of edaravone were observed in mice receiving 1.0 or 3.0 mg/kg of edaravone immediately after impact, but not at a lower dose of 0.1 mg/kg. This antidepressant effect persisted up to 1 h after impact, whereas edaravone treatment at 3 h after impact had no effect on concussion-induced depressive-like behavior. These results suggest that edaravone protects against concussion-induced depression, and this protection is mediated by suppression of OS and 5-LOX translocation.
- Subjects :
- Animals
Antipyrine pharmacology
Antipyrine therapeutic use
Brain pathology
Brain Chemistry drug effects
Brain Concussion pathology
Depressive Disorder etiology
Dose-Response Relationship, Drug
Edaravone
Enzyme Activation drug effects
Male
Mice
Mice, Inbred C57BL
Neuroprotective Agents pharmacology
Psychomotor Performance drug effects
Swimming psychology
Antipyrine analogs & derivatives
Arachidonate 5-Lipoxygenase metabolism
Brain Concussion complications
Brain Concussion psychology
Depressive Disorder drug therapy
Depressive Disorder psychology
Lipoxygenase Inhibitors therapeutic use
Neuroprotective Agents therapeutic use
Oxidative Stress drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1557-9042
- Volume :
- 31
- Issue :
- 20
- Database :
- MEDLINE
- Journal :
- Journal of neurotrauma
- Publication Type :
- Academic Journal
- Accession number :
- 24849726
- Full Text :
- https://doi.org/10.1089/neu.2014.3331